Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Zelira Therapeutics Ltd
ZLDCurrent price
0.74 AUD
+0.02 AUD (+2.78%)
Last closed
0.74 AUD
Company
www.zeliratx.com
ISIN
AU000000ZLD1
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
7 641 471 AUD
Yield for 12 month
-25.25 %
1Y
3Y
5Y
10Y
15Y
ZLD
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter products, including SprinJene, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia. Address: 101 St Georges Terrace, Perth, WA, Australia, 6000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17.19 AUDP/E ratio
–Dividend Yield
–Current Year
+94 034 AUD
Last Year
+298 208 AUD
Current Quarter
+39 841 AUD
Last Quarter
+54 193 AUD
Current Year
-1 374 682 AUD
Last Year
-3 184 959 AUD
Current Quarter
-280 343 AUD
Last Quarter
-1 094 340 AUD
Key Figures ZLD
1 year
3 years
5 years
10 years
EBITDA
-5 490 054 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.87 %
PEG Ratio
–
Return On Equity TTM
-266.82 %
Wall Street Target Price
17.19 AUD
Revenue TTM
94 034 AUD
Book Value
-0.39 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-82.1 %
Dividend Yield
–
Gross Profit TTM
-324 782 AUD
Earnings per share
-3.19 AUD
Diluted Eps TTM
-3.19 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ZLD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ZLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:175
Payout Ratio
–
Last Split Date
14.04.2022
Dividend Date
–
Stock Valuation ZLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
137.7437
Price Sales TTM
81.2631
Enterprise Value EBITDA
-1.0946
Price Book MRQ
0.3247
Financials ZLD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ZLD
For 52 weeks
0.28 AUD
1.09 AUD
50 Day MA
0.7 AUD
Shares Short Prior Month
–
200 Day MA
0.7 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart